Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,622 | -71,174 | -250,157 | -181,361 | -121,359 |
| Depreciation Amortization | 3,028 | 1,400 | 8,022 | 6,231 | 4,130 |
| Accounts payable and accrued liabilities | -3,092 | -3,806 | 2,203 | -3,250 | 709 |
| Other Working Capital | -20,801 | -19,337 | -18,391 | -22,889 | -12,540 |
| Other Operating Activity | 34,887 | 16,333 | 29,507 | 25,345 | 12,718 |
| Operating Cash Flow | $-10,600 | $-76,584 | $-228,816 | $-175,924 | $-116,342 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,301 | -4,068 | -9,821 | -6,360 | -5,113 |
| Purchase Of Investment | -4,426 | -4,426 | -48,221 | -36,138 | -36,138 |
| Sale Of Investment | 22,983 | 11,233 | 140,470 | 119,000 | 77,622 |
| Investing Cash Flow | $13,256 | $2,739 | $82,428 | $76,502 | $36,371 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 103,378 | N/A | 27,606 | 27,606 | 27,606 |
| Debt Repayment | -52,860 | N/A | -1,907 | -1,907 | -1,907 |
| Common Stock Issued | 13,315 | 5,656 | 103,903 | 102,585 | 1,279 |
| Other Financing Activity | 0 | 0 | 0 | -3,279 | 0 |
| Financing Cash Flow | $63,833 | $5,656 | $129,602 | $125,005 | $26,978 |
| Exchange Rate Effect | 1 | N/A | -1 | -2 | 0 |
| Beginning Cash Position | 171,215 | 171,215 | 188,002 | 188,002 | 188,002 |
| End Cash Position | 237,705 | 103,026 | 171,215 | 213,583 | 135,009 |
| Net Cash Flow | $66,490 | $-68,189 | $-16,787 | $25,581 | $-52,993 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,600 | -76,584 | -228,816 | -175,924 | -116,342 |
| Capital Expenditure | -5,301 | -4,068 | -9,821 | -6,360 | -5,113 |
| Free Cash Flow | -15,901 | -80,652 | -238,637 | -182,284 | -121,455 |